Ahmed Amleh

Ahmed Amleh

Auto-generated profile, based on publicly available information

Ahmed Amleh

Erciyes Universitesi

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2026 in Journal of Research in Pharmacy
Verified
Journal Article
Closed access
GBGuzide Satir Basaran
Guzide Satir Basaran
GSGülay Sezer
Gülay Sezer
MYMerve Yıldırım
Merve Yıldırım
BABeyzanur Aktaş
Beyzanur Aktaş
AAAhmed Amleh
Ahmed Amleh
MHMUHAMMED İHSAN HAN
MUHAMMED İHSAN HAN
In this study, a new 1,2,4-triazole ring that has a 2-fluorophenyl ring was synthesized using (S)-Naproxen as the starting molecule. The target compound was characterized using spectroscopic methods such as FT-IR, 1H-NMR, 13C-NMR, and HR-MS. In molecular modeling studies, compound (4a) was used to control for the Bcl-2 apoptotic marker. The main aim was to show that the MDA-MB-231 cell line developed growth inhibition in a dose-dependent manner after compound treatment. The results showed that compound (4a) inhibited the motility of MDA-MB-231 cells. Compound (4a) at 75, 150, and 300 µM concentrations significantly reduced the viability of MDA-MB-231 cells compared to the control group. IC50 value of the compound (4a) for 48 h was 57.6 µM. In our study, for the first time, miR-133a-5p was significantly up-regulated in MDA-MB-231 breast cancer cells treated with compound (4a) at different concentrations compared to the control group. As such, miR-133a-5p could play an essential role in tumorigenesis by targeting Bcl-2 in MDA-MB-231 and may be a biomarker for therapeutic targets in breast cancer treatment.